MH, B., B, Y., C, B., M, C., & L, C. (2026). Development and validation of high-dose methotrexate population pharmacokinetic models to inform clinical decisions on dosing. European journal of clinical pharmacology, 82(6), . https://doi.org/10.1007/s00228-026-04080-0
Chicago Style (17th ed.) CitationMH, Blackman, Yelvington B, Beck C, Cortez M, and Choi L. "Development and Validation of High-dose Methotrexate Population Pharmacokinetic Models to Inform Clinical Decisions on Dosing." European Journal of Clinical Pharmacology 82, no. 6 (2026). https://doi.org/10.1007/s00228-026-04080-0.
MLA (9th ed.) CitationMH, Blackman, et al. "Development and Validation of High-dose Methotrexate Population Pharmacokinetic Models to Inform Clinical Decisions on Dosing." European Journal of Clinical Pharmacology, vol. 82, no. 6, 2026, https://doi.org/10.1007/s00228-026-04080-0.